These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12767517)
1. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517 [TBL] [Abstract][Full Text] [Related]
2. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831 [TBL] [Abstract][Full Text] [Related]
4. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance. Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557 [TBL] [Abstract][Full Text] [Related]
5. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma. Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191 [TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217 [TBL] [Abstract][Full Text] [Related]
7. Analysis of new biomarkers for cholangiocarcinoma. Miwa M; You G; Tanaka H; Taniguchi S; Fujii T; Kamemura K; Suzaki M; Isono T; Tooyama I; Tanaka M; Srivatanakul P; Viwatthanasittiphong C; Sangrajrang S; Khuhaprema T J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):397-8. PubMed ID: 24446393 [TBL] [Abstract][Full Text] [Related]
8. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171 [TBL] [Abstract][Full Text] [Related]
9. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy. Leelawat K; Sakchinabut S; Narong S; Wannaprasert J BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942 [TBL] [Abstract][Full Text] [Related]
10. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC). Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034 [TBL] [Abstract][Full Text] [Related]
11. Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. Leelawat K; Leelawat S; Ratanachu-Ek T; Trubwongchareon S; Wannaprasert J; Tripongkaruna S; Chantawibul S; Tepaksorn P World J Gastroenterol; 2006 Jul; 12(26):4195-8. PubMed ID: 16830373 [TBL] [Abstract][Full Text] [Related]
12. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study. Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229 [TBL] [Abstract][Full Text] [Related]
13. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. Matull WR; Andreola F; Loh A; Adiguzel Z; Deheragoda M; Qureshi U; Batra SK; Swallow DM; Pereira SP Br J Cancer; 2008 May; 98(10):1675-81. PubMed ID: 18475301 [TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy. Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654 [TBL] [Abstract][Full Text] [Related]
15. The expression of MUC mucin in cholangiocarcinoma. Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262 [TBL] [Abstract][Full Text] [Related]
16. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244 [TBL] [Abstract][Full Text] [Related]
17. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. Boonla C; Sripa B; Thuwajit P; Cha-On U; Puapairoj A; Miwa M; Wongkham S World J Gastroenterol; 2005 Aug; 11(32):4939-46. PubMed ID: 16124042 [TBL] [Abstract][Full Text] [Related]
18. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis. Pabalan N; Sukcharoensin S; Butthongkomvong K; Jarjanazi H; Thitapakorn V J Gastrointest Cancer; 2019 Mar; 50(1):54-61. PubMed ID: 29139058 [TBL] [Abstract][Full Text] [Related]
19. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Silsirivanit A; Araki N; Wongkham C; Vaeteewoottacharn K; Pairojkul C; Kuwahara K; Narimatsu Y; Sawaki H; Narimatsu H; Okada S; Sakaguchi N; Wongkham S Cancer Sci; 2013 Oct; 104(10):1278-84. PubMed ID: 23809433 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns. Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]